Authors Dashti SG, Buchanan DD, Jayasekara H, et al. Citation Cancer Epidemiol Biomarkers Prev. 2017 Mar;26(3):366-375. PubMedLink https://pubmed.ncbi.nlm.nih.gov/27811119/ PMCID PMC5336397
Modeling of successive cancer risks in Lynch syndrome families in the presence of competing risks using copulas.
Authors Choi YH, Briollais L, Win AK, et al. Citation Biometrics. 2017 Mar;73(1):271-282. PubMedLink https://pubmed.ncbi.nlm.nih.gov/27378229/ PMCID PMC5319907
Risk of colorectal cancer for carriers of a germ-line mutation in POLE or POLD1.
Authors Buchanan DD, Stewart JR, Clendenning M, et al. Citation Genet Med. 2017 Nov 9. PubMedLink https://pubmed.ncbi.nlm.nih.gov/29120461/ PMCID PMC5943186
Lack of evidence for germline RNF43 mutations in patients with serrated polyposis syndrome from a large multinational study.
Authors Buchanan DD, Clendenning M, Zhuoer L, et al. Citation Gut. 2017 Jun;66(6):1170-1172. PubMedLink https://pubmed.ncbi.nlm.nih.gov/27582512/ PMCID NA
Tumor testing to identify lynch syndrome in two Australian colorectal cancer cohorts.
Authors Buchanan DD, Clendenning M, Rosty C, et al. Citation J Gastroenterol Hepatol. 2017 Feb;32(2):427-438. PubMedLink https://pubmed.ncbi.nlm.nih.gov/27273229/ PMCID PMC5140773